The inflammatory status and lymph node metastases in non-small cell lung cancer
Автор: Pismenny Dmitry S., Savelieva Olga E., Zavyalova Marina V., Rodionov Evgeny O., Tashireva Liubov A., Tuzikov Sergey A., Pankova Olga V., Perelmuter Vladimir M.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Клинические исследования
Статья в выпуске: 3 т.19, 2020 года.
Бесплатный доступ
Introduction. The development of inflammation is characterized by changes in blood hematology parameters and indices. Various inflammatory parameters are used to assess the inflammatory status (iS) during cancer treatment. Recent studies have revealed a relationship between tumor progression and the presence of chronic inflammation. Consequently, there have been many attempts to predict the risk of tumor recurrence and distant metastases, as well as patient's survival assessing the various inflammatory markers. The relationship between iS parameters and lymph node metastasis remains poorly understood in non-small cell lung cancer (NSCLC). Material and Methods. The prospective study included 35 patients with NSCLC (T1-4N0-2M0). Seventeen patients received 2-3 cycles of neoadjuvant chemotherapy (NAC). A leukocyte formula was determined in the peripheral blood and inflammatory indices, such as neutrophils to lymphocytes ratio (NLR), platelets to lymphocytes ratio (PLR), lymphocytes to monocytes ratio (LMR) and systemic immuno-inflammatory index (Sii) were calculated. in addition, the concentrations of fibrinogen, C-reactive protein (CRP) and cortisol were evaluated. Results. NAC alone did not significantly change the parameters of patients' iS. Lymph node metastases were associated with changes in parameters indicating the enhanced iS. in the group of patients who did not receive NAC, lymph node metastasis was associated with fibrinogen blood levels (cut-off value 5.35 g/L), PLR index value (cut-off value 7.18) and cortisol blood concentration (cut-off value 414 nmol/mL). The confidence level was x2=10.118; р=0.018. in the group of patients who received NAC, lymph node metastasis was associated with the leukocyte count (cut-off value 7.1*109/L), PLR index value (cut-off value is 7.18) and CRP blood concentration (cut-off value is 8.5 mg/L). The confidence level was x2=8.193; р=0.042. Conclusion. Risk of lymph node metastasis in NSCLC is associated with iS. Parameters of iS can be used to predict the risk of lymph node metastases.
Non-small cell lung cancer, inflammatory status, neoadjuvant chemotherapy, lymph node metastasis
Короткий адрес: https://sciup.org/140254353
IDR: 140254353 | DOI: 10.21294/1814-4861-2020-19-3-54-63
Список литературы The inflammatory status and lymph node metastases in non-small cell lung cancer
- Candido J., Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013 Jan; 33 Suppl 1: S79-84. doi: 10.1007/s10875-012-9847-0.
- ПерельмутерВ.М., МанскихВ.Н. Прениша как отсутствующее звено концепции метастатических ниш, объясняющее избирательное метастазирование злокачественных опухолей и форму метастатической болезни. Биохимия. 2012; 77(1): 130-139. [Perelmuter V.M., Manskih V.N. Preniche as missing link of the metastatic niche concept explaining organ-preferential metastasis of malignant tumors and the type of metastatic disease. Biochemistry. 2012; 77(1): 130-139. (in Russian)]. doi: 10.1134/ S0006297912010142.
- Barcellos-Hoff M.H., Lyden D., Wang T.C. The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer. 2013 Jul; 13(7): 511-8. doi: 10.1038/nrc3536.
- Retsky M., Demicheli R., Hrushesky W.J., Forget P., De Kock M., Gukas I., Rogers R.A., Baum M., Pachmann K., Vaidya J.S. Promising development from translational or perhaps anti-translational research in breast cancer. Clin Transl Med. 2012 Aug 28; 1(1): 17. doi: 10.1186/20011326-1-17.
- Zhao Z., ZhaoX., Lu J., Xue J., Liu P., MaoH. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies. Arch Gynecol Obstet. 2018 Apr; 297(4): 849-857. doi: 10.1007/s00404-018-4678-8.
- YuX., Wen Y., Lin Y., ZhangX., Chen Y., Wang W., Wang G., ZhangL. The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer. 2018 Feb 12; 9(5): 807-815. doi: 10.7150/jca.22755.
- Chen S., Guo J., Feng C., Ke Z., Chen L., Pan Y. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol. 2016 May; 8(3): 160-7. doi: 10.1177/1758834016638019.
- SunH., Yin C.Q., Liu Q., WangF., Yuan C.H. Clinical Significance of Routine Blood Test-Associated Inflammatory Index in Breast Cancer Patients. Med Sci Monit. 2017 Oct 25; 23: 5090-5095. doi: 10.12659/ msm.906709.
- Feng J.F., Chen S., YangX. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore). 2017; 96(4): e5886. doi: 10.1097/MD.0000000000005886.
- Geng Y., Shao Y., Zhu D., Zheng X., Zhou Q, Zhou W, Ni X., Wu C., Jiang J. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis. Sci Rep. 2016 Dec 21; 6: 39482. doi: 10.1038/ srep39482.
- Ma M., Yu N., Wu B. High systemic immune-inflammation index represents an unfavorable prognosis of malignant pleural mesothelioma. Cancer Manag Res. 2019 May 2; 11: 3973-3979. doi: 10.2147/CMAR. S201269.
- Stotz M., Pichler M., Absenger G., Szkandera J., Arminger F., Schaberl-MoserR., SamoniggH., Stojakovic T., GergerA. The preopera-tive lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014 Jan 21; 110(2): 435-40. doi: 10.1038/bjc.2013.785.
- Chan J.C., Chan D.L., Diakos C.I., Engel A., Pavlakis N., Gill A., Clarke S.J. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2017 Mar; 265(3): 539-546. doi: 10.1097/ SLA.0000000000001743.
- СельеГ., СаармаЮ.М., ЛукаА.Н., ХоролИ.С. Стресс без дистресса. М., 1979. 126 с. [Selye H., Saarma Ju.M., Luka A.N., Horol I.S. Stress without Distress. Moscow, 1979. 126 p. (in Russian)].
- Гаркави Л.Х., Квакша Е.Б., Уколова М.А. Адаптационные реакции и резистентность организма. Ростов-на-Дону, 1990. 256 с. [Garkavi L.H., Kvakina E.B., UkolovaM.A. Adaptation reactions and body resistance. Rostov-on-Don, 1990. 256 p. (in Russian)].
- Karagiannis G.S., Pastoriza J.M., Wang Y., Harney A.S., Entenberg D., Pignatelli J., Sharma V.P., Xue E.A., Cheng E., D'Alfonso T.M., Jones J.G., Anampa J., RohanT.E., Sparano JA., Condeelis J.S., OktayM.H. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med. 2017 Jul 5; 9(397): eaan0026. doi: 10.1126/scitranslmed.aan0026.
- Zhang Y., Xiao G., Wang R. Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis. Cancer Manag Res. 2019 May 7; 11: 4185-200. doi: 10.2147/CMAR.S190006.
- Shoenfeld Y., Gurewich Y., Gallant L.A., Pinkhas J. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med. 1981 Nov; 71(5): 773-8. doi: 10.1016/0002-9343(81)90363-6.
